Application of built-in adjuvants for epitope-based vaccines

Y Lei, F Zhao, J Shao, Y Li, S Li, H Chang, Y Zhang - PeerJ, 2019 - peerj.com
Several studies have shown that epitope vaccines exhibit substantial advantages over
conventional vaccines. However, epitope vaccines are associated with limited immunity …

DARPin based GMR Biosensor for the detection of ESAT-6 Tuberculosis Protein

S Gupta, V Kakkar - Tuberculosis, 2019 - Elsevier
Tuberculosis (TB), a life threatening communicable disease, is mainly caused by the
bacterium named Mycobacterium tuberculosis (MTB). This high burden infectious threat is …

Design of Broadly Cross-Reactive M Protein–Based Group A Streptococcal Vaccines

MP Aranha, TA Penfound, S Salehi… - The Journal of …, 2021 - journals.aai.org
Group A streptococcal infections are a significant cause of global morbidity and mortality. A
leading vaccine candidate is the surface M protein, a major virulence determinant and …

[HTML][HTML] Immunological depiction of synthetic B-cell epitopes of Mycobacterium tuberculosis

N Sharma, V Khandelwal, S Kumar… - The International …, 2023 - journals.lww.com
Background: To combat the tuberculosis (TB) epidemic, the development of a better and
faster diagnosis or more effective vaccine is essential. Pulmonary TB (PTB) is one of the …

The chamber of secretome in Mycobacterium tuberculosis as a potential therapeutic target

M Dwivedi, K Bajpai - Biotechnology and Genetic Engineering …, 2023 - Taylor & Francis
Mycobacterium tuberculosis (MTB) causes one of the ancient diseases, Tuberculosis, affects
people around the globe and its severity can be understood by its classification as a second …

A label-free immunosensor based on E-SMS optical fiber structure for rapid Ag85B detection of tuberculosis

B Patiño-Jurado, A Gaviria-Calderón… - Optical Fiber …, 2024 - Elsevier
Tuberculosis, caused by Mycobacterium tuberculosis bacillus, is one of the most prevalent,
widespread, infectious, and deadliest diseases in the world. In this work, a compact and …

IMB-BZ as an inhibitor targeting ESX-1 secretion system to control mycobacterial infection

P Jia, Y Zhang, J Xu, M Zhu, S Peng… - The Journal of …, 2022 - academic.oup.com
Background Resistance to anti-tuberculosis (TB) drugs is a major issue in TB control, and
demands the discovery of new drugs targeting the virulence factor ESX-1. Methods We first …

Exploration of some new secretory proteins to be employed for companion diagnosis of Mycobacterium tuberculosis

DK Tripathi, K Srivastava, KL Nagpal, PK Shukla… - Immunology …, 2019 - Elsevier
Tuberculosis (TB) is a highly infectious disease and its early and precise diagnosis is
essential to reduce morbidity and mortality of patients. Since the routine diagnostic tests (like …

Immunological characterization of chimeras of high specificity antigens from Mycobacterium tuberculosis H37Rv

F Fatma, DK Tripathi, M Srivastava, KK Srivastava… - Tuberculosis, 2021 - Elsevier
Tuberculosis remains a serious global health problem. BCG is the only prophylactic TB
vaccine and it shows variable protective efficacy. Chimeric protein subunit vaccines hold …

[图书][B] Investigations of the Virulence Mechanisms of Mycobacterium marinum

MJ Ferrell - 2020 - search.proquest.com
Mycobacterium tuberculosis causes Tuberculosis (TB), the leading cause of death globally
from a single infectious disease. TB eradication will require improved control strategies …